Bone marrow transplant is practice since several decades in develops countries and plays an important role in achieving a complete remission or cure for most hematology malignancy diseases. Unfortunately it remains unavailable in most of developing countries in general and partic...
Open access
Research Article10.9734/ibrr/2025/v16i4368
Boidy Kouakou, Edgard Julien Sonkwa Lontsi, Yao Nicaise Atiméré, Alexis Dohoma Silué, Ismael Kamara, Danho Clotaire Nanho, Ruth Djeket, Emeraude Ndathz-Comoé, Daouda Koné, Norman Isaac Klebair Kouamé, Emmanuela Hiabba Assohou-Koffi & Gustave Kouassi Koffi·International Blood Research & Reviews·2025
Background: Hodgkin lymphoma is the first hematology malignancy to be cured. The Management of mediastinal or pulmonary location, whether inaugural or secondary, is restricted with conventional chemotherapy which contains cardio- or pneumotoxic molecules. The new Advanced therape...
Open access
Research Article10.9734/ibrr/2025/v16i4372
Boidy Kouakou, Edgard Julien Sonkwa Lontsi, Alexis Dodoma Silué, Yao Nicaise Atiméré, Ismael Kamara, Danho Clotaire Nanho, Ruth Djeket, Emeraude Ndathz-Comoé, Daouda Koné, Norman Isaac Klebair Kouamé, Emmanuela Hiabba Assohou-Koffi & Gustave Kouassi Koffi·International Blood Research & Reviews·2025
Introduction: Sickle cell disease (SCD) is the most common hemoglobinopathy worldwide. It is of significant public health importance in Sub-Saharan Africa. The SCD nephropathy is a major contributor to the morbidity and mortality. The Early detection and prevention of Albuminuria...
Open access
Research Article10.9734/ibrr/2025/v16i4370